Workflow
孤独症智能体StellarCare AI
icon
Search documents
钱塘江畔聚智赋能 AI+平台助推生物医药“加速跑”
Mei Ri Shang Bao· 2025-10-24 05:40
开栏语:今年以来,浙江省以"人工智能+"行动为牵引,杭州市全力打造人工智能创新发展高地,各地 全力竞逐人工智能新赛道。钱塘(新)区勇担使命,立足区内雄厚的产业基础与创新沃土,精准聚焦 AI医药、具身智能、高端芯片三大特色赛道,加速布局未来产业,汇聚创新动能。《AI聚钱塘 智创新 高地》今日开栏,旨在深入一线,解读产业布局、追踪技术突破、展示前沿成果,生动诠释以科技创新 为核心的新质生产力,向您呈现一个活力奔涌的钱塘新图景。 在今年8月钱塘举办的"AI+生物医药"创新研讨会上,浙大智药院副院长曹戟表示,类似的技术攻坚在 钱塘已经上演了200多次,目前浙大智药研究院在钱塘已与安域生物、歌礼生物等15家企业共建联合研 发中心,并成功孵化禹泓医药等7家医药企业,承接项目140余项。 "研究院为我们提供从靶点确证、分子优化到非临床评价的全链条,"禹泓医药负责人表示,"YH001项 目快速推进至临床Ⅱ期,帮助我们完成了超过1亿元的融资,企业估值已达准独角兽标准。" 产业集群崛起,筑牢高质量发展根基 随着高能级平台赋能效应持续释放,钱塘生物医药产业已实现从 "企业单点突破"到 "集群协同发展"的 跨越,构建起覆盖研发、生产 ...
当AI遇上生物医药,看钱塘如何抢占“奇点”
Hang Zhou Ri Bao· 2025-07-08 03:01
Core Insights - The article highlights the rapid advancements in AI-driven drug development in Hangzhou, particularly in the Qiantang (New) District, which is becoming a hub for the integration of AI and biomedicine [4][6][8] Group 1: AI in Drug Development - Derui Zhiyao's first AI-designed oral small molecule drug, MDR-001, has successfully entered clinical trials, offering new treatment options for overweight patients [4] - The company has developed a one-stop drug research and development platform, Molecule Pro™, which significantly reduces the time and cost of drug development by 50% and saves 1.5 to 3 years compared to traditional methods [6][7] - The Zhejiang University Intelligent Innovation Drug Research Institute has been instrumental in supporting local pharmaceutical companies with AI technology, leading to the incubation of seven drug companies in the Qiantang area [7][8] Group 2: Industry Growth and Investment - Qiantang District has established a comprehensive ecosystem for biomedicine, including preclinical research, clinical trial platforms, and full-chain industrialization processes [9] - The district's industrial fund has exceeded 45 billion yuan, with investments in 266 companies, including 71 unicorns, showcasing strong financial backing for the biomedicine sector [9] - Recent discussions at the Zhejiang Provincial High-level Talent Conference highlighted the potential of AI in transforming biomedical understanding and practices, indicating a forward-looking approach to industry development [8][9]